Prosensa Holding N.V. (RNA) Tops Q3 EPS by 4c

Prosensa Holding N.V. (NASDAQ: RNA) reported Q3 EPS of ($0.71), $0.04 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $2.21 million.

For earnings history and earnings-related data on Prosensa Holding N.V. (RNA) click here.

You May Also Be Interested In

• Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
• Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'
• AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c